has tirzepatide been discontinued Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute 🚨 Alert: Tirzepatide No Longer

According to NICE guidance (NG28), these medications have demonstrated significant benefits in glycaemic control, with some specific agents (semaglutide, liraglutide, dulaglutide) also showing cardiovascular risk reduction in clinical trials

Most providers recommend starting at 0.25 mg weekly and waiting 4 weeks (rather than 2-3 weeks) before increasing, because post-surgical digestion is already compromised and adding a powerful anti-nausea medication too quickly can overwhelm your system

Before each injection, patients should visually inspect the medication through the pen's viewing window

Philip Pape 30:36 So that's a lot

Who Should Consider This Combination, and Important Safety Guardrails Combination therapy may be appropriate for patients with documented suboptimal weight loss on semaglutide monotherapy, adequate GI tolerance, and provider-confirmed medical necessity

Quick tip: When reading trial results, separate average weight change from personal expectations